Cough, Cold and Allergy (Hay Fever) Remedies

Vietnam has been experiencing a higher number of cases of influenza in 2023, which is benefiting sales of cough, cold and allergy (hay fever) remedies. Due to prolonged home seclusion as a result of pandemic-related restrictions, Vietnamese consumers…

Cough, cold and allergy remedies face favourable growth in 2023, with the category boosted by the return to normal social lifestyles post-pandemic. The regular circulation of seasonal cold viruses is fuelling demand, which had previously fallen due…

With value sales of cough and cold and allergy ( hay fever) remedies reducing to more normal levels. as concern about COVID-19 abate, there is expected to be a decline in volume sales in 2023. The exception being medicated confectionery. Along with…

Manufacturers have raised their prices due to the rising costs of energy, raw materials, production and logistics amid a highly inflationary climate. Nonetheless, in many cases, consumers have continued to buy the more expensive branded options as…

In Tunisia, there is a strong preference for unit-dose sachets among consumers when it comes to cough, cold and allergy (hay fever) remedies. This format is highly popular and widely used, with brands like Fervex, Gripex, and Doliprex being prominent…

Cough, cold and allergy (hay fever) remedies continued to enjoy healthy growth in current value terms in 2023. This was driven, to a large extent, by the revival of normal pre-pandemic patterns of behaviour, including the return of Thais to their…

Current value sales of cough, cold and allergy (hay fever) remedies rebounded to pre-pandemic levels in 2022 as the UK experienced its strongest cold and flu season in recent years, as a result of greater socialising as restrictions eased, thereby…

In 2023, cough, cold and allergy (hay fever) remedies is set to see dynamic current growth, on top of an extremely strong performance in 2022. Within the category, after medicated confectionery, growth is set to be driven by and paediatric cough/cold…

The increasingly dusty weather in the United Arab Emirates is causing a rise in allergies and respiratory illnesses amongst consumers. In particular, in August 2022 there were so many dust storms that doctors in Abu Dhabi and Dubai issued a warning…

In the Philippines, one interesting aspect of OTC products in general and cough, cold and allergy (hay fever) remedies in particular is that consumers are generally very aware of the active ingredients that are contained within these products and the…

Cough, cold, and allergy (hay fever) remedies is projected to continue to post retail current value growth in 2023, following a severe decline in 2020 due to the Coronavirus (COVID-19) pandemic. Having passed the 2019 pre-pandemic level in 2022, the…

In 2022, cough, cold and allergy (hay fever) remedies was marked by increases in demand for products to soothe sore throat and cough complaints. This development was a result of extremely high morbidity throughout the year. In the first half of 2022,…

In line with rising health-consciousness, people in Taiwan are becoming more worried about the potentially hazardous side effects and contraindications of active pharmaceutical ingredients in standard OTC medications. This has continued to buoy…

Cough, cold and allergy (hay fever) remedies have witnessed stronger growth in 2023, due to warmer weathers and increased time spent out of the home. Warmer weather in Switzerland has led to an increase in pollen and the incidence of allergic…

Cough, cold and allergy (hay fever) remedies remained the largest product area within consumer health in Sweden in 2023. Following a two-year period of buoyant volume growth for most subcategories, demand weakened significantly in 2023, This was due…

After the surge in sales that cough, cold and allergy (hay fever) remedies experienced in 2022, demand is waning in 2023, with the category recording more subdued growth rates. Traditionally, sales of cough, cold and allergy (hay fever) remedies in…

During the review period, the flu and allergy season in South Africa was rife specifically during the winter periods. Given the presence of several flu strains and allergies, consumers reached out to cough, cold and allergy (hay fever) products to…

Like analgesics, sales of cough, cold and allergy (hay fever) remedies continue to rise, benefiting from the “tripledemic” of rising COVID-19 cases, the stronger return of influenza due to greater mobility outside of the home and contact with others,…

During the past few years, Slovenia has experienced a virtually non-existent flu season due to the outbreak of COVID-19. This led to individuals opting to stay at home and, when going out in public, adhering to practices like wearing face masks,…

In Slovakia, cough, cold and allergy (hay fever) remedies was characterised by very strong increases in retail volume sales of OTC remedies for sore throats, coughs and colds. The high demand was the result of extremely high morbidity throughout the…